Infographic: Repurposing Strategies

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

Written byAnna Azvolinsky
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

PATENT VERSUS EXCLUSIVITY

Patents: Granted by the US Patent and Trademark Office (or an analogous agency in another country). Patents generally last for 20 years.

Exclusivity: Granted by the FDA upon drug approval. Exclusive marketing rights, which
range from six months to seven years, give a manufacturer sole promotion rights of a drug for a certain indication as an incentive for drug innovation and prevention of generic drug competition.

Off-label drug use: When a drug is used in a different disease, administered in a different
way or at a different dose than what has been specified in the drug’s label (based on clinical trial data reviewed by the FDA for approval). Any drug on the market can be prescribed on an off-label basis at doctors’ discretion.

Read the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control